News of the WeekGenomics

University Company to Exploit Heart Data

+ See all authors and affiliations

Science  30 Jun 2000:
Vol. 288, Issue 5475, pp. 2301-2303
DOI: 10.1126/science.288.5475.2301

You are currently viewing the summary.

View Full Text

Summary

BOSTON-- This month, Boston University, which directs the Framingham Heart Study, a massive government effort begun in 1948 to monitor the cardiovascular health of more than 10,000 residents of this suburb of Boston, announced plans to form a bioinformatics company that will mine the data. The university will own 20% of Framingham Genomic Medicine Inc., which hopes to raise $21 million to begin modernizing the immense database and packaging it in a format that will be valuable to the pharmaceutical industry. The plan raises a host of difficult ethical issues, including patient privacy, academic conflicts of interest, and reciprocal value to the Framingham residents whose medical data will form the basis for the new enterprise.

Related Content